Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
The Netherlands Journal of Medicine
|
August 25, 2006
Guidelines for treatment with infliximab for Crohn's disease
D W Hommes, B Oldenburg, A A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics
|
May 29, 2002
Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease
B P J van Balkom, E J Schoon, R W Stockbrügger, et al.
British Journal of Cancer
|
October 15, 2009
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease
M W M D Lutgens, B Oldenburg, P D Siersema, et al.
Inflammatory Bowel Diseases
|
August 11, 2011
Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study
A C W Vos, N Bakkal, R C Minnee, et al.
Gut
|
February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease
W Reinisch, D W Hommes, G Van Assche, et al.
Revista De Gastroenterologia De Mexico
|
March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]
G van Assche, A Dignass, B Bokemeyer, et al.
Gut
|
March 14, 2008
High frequency of early colorectal cancer in inflammatory bowel disease
M W M D Lutgens, F P Vleggaar, M E I Schipper, et al.
Inflammatory Bowel Diseases
|
February 21, 2009
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis
M M H Claessen, M W M D Lutgens, H R van Buuren, et al.
Alimentary Pharmacology & Therapeutics
|
May 24, 2023
Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease
J E Kreijne, R L Goetgebuer, N S Erler, et al.
Alimentary Pharmacology & Therapeutics
|
March 12, 2014
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
S S M Chan, R Luben, A Olsen, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
The Netherlands Journal of Medicine
|
August 25, 2006
Guidelines for treatment with infliximab for Crohn's disease
D W Hommes, B Oldenburg, A A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics
|
May 29, 2002
Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease
B P J van Balkom, E J Schoon, R W Stockbrügger, et al.
British Journal of Cancer
|
October 15, 2009
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease
M W M D Lutgens, B Oldenburg, P D Siersema, et al.
Inflammatory Bowel Diseases
|
August 11, 2011
Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study
A C W Vos, N Bakkal, R C Minnee, et al.
Gut
|
February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease
W Reinisch, D W Hommes, G Van Assche, et al.
Revista De Gastroenterologia De Mexico
|
March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]
G van Assche, A Dignass, B Bokemeyer, et al.
Gut
|
March 14, 2008
High frequency of early colorectal cancer in inflammatory bowel disease
M W M D Lutgens, F P Vleggaar, M E I Schipper, et al.
Inflammatory Bowel Diseases
|
February 21, 2009
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis
M M H Claessen, M W M D Lutgens, H R van Buuren, et al.
Alimentary Pharmacology & Therapeutics
|
May 24, 2023
Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease
J E Kreijne, R L Goetgebuer, N S Erler, et al.
Alimentary Pharmacology & Therapeutics
|
March 12, 2014
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
S S M Chan, R Luben, A Olsen, et al.
Page
of 11